Himax Techs (NASDAQ:HIMX) Stock, Quote.Headers.trade-ideas

Himax Techs

Himax Technologies

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue gets derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

Ciena

News

Intraday Update

Markets

Movers

Trading Ideas

BTDR

CIEN

GAMB

HIMX

JUNS

LQDT

RADX

RIOT

Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On Thursday

stock buyback

Equities

Penny Stocks

Buybacks

General

Himax Technologies shares rise in premarket after announcing a $20 million share buyback program and highlighting long-term growth prospects.

What&#39;s Going On With Himax Technologies Stock Wednesday?

Earnings

Guidance

Tech

Himax Technologies reports 6.8% revenue decline in Q3, beating analyst estimates. Earnings per ADS beat consensus, stock price rose. Guidance for Q4 is flat.

Himax Q3 Earnings: Revenue Beats Forecast, CEO Highlights Growth in Automotive, AI, OLED Sectors, Sets Cautious Q4 Guidance

Himax Technologies, Inc. - American depositary shares, each of which represents two ordinary shares.

Himax Technologies Inc

Himax And Calumino Collaborate To Launch Advanced CMOS Imager-Based Thermal Sensor For AI Applications

Himax Partners With Ganzin To Launch Energy-Efficient Eye-Tracking Solution For AR Glasses At CES 2025

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>), an industry leader in fabless display driver ICs and other semiconductors, today announced the Company will introduce its expanded WiseEyeTM PalmVein suite at CES 2025, featuring groundbreaking bimodal palm vein and face authentication technologies. This game-changing, contactless, ultralow power bimodal biometric authentication is designed to enhance both security and user friendliness in smart door locks. By leveraging multiple personal biometric traits for authentication, the newly introduced solution delivers unparalleled security, seamless adaptability and a robust, user-friendly experience, ensuring authentication performance across various scenarios and environments.

Himax To Unveil Next-Gen Biometric Tech for Smart Locks at CES 2025

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>), an industry leader in fabless display driver ICs and other semiconductors, today announced that the Company and its AI ecosystem partners will unveil a suite of innovative, production-ready AIoT applications at CES 2025, powered by Himax's groundbreaking ultralow power WiseEye Module solutions. These designs will showcase intuitive, user-friendly AI capabilities set to transform multiple industries by improving productivity, scalability, automation, and efficiency, all while delivering better performance and lower power consumption. Himax's ultralow power WiseEye Module solutions are leading the AIoT revolution with their advanced, efficient, and scalable AI-driven technologies.
The Himax WiseEye Module seamlessly integrates ultralow power WiseEye AI processors and proprietary always-on CMOS sensors, designed with compact form factors, high integration, and plug-and-play functionality. Characterized by remarkably low power consumption at just single-digit milliwatts, it is ideal for battery-powered endpoint devices that cater to everyday life. The WiseEye Module incorporates versatile AI models from in-house or third-party partners, enabling no-code/low-code AI development for use cases like people counting, gesture recognition, human detection, face recognition, and audio command classification. This simplifies the AI development process, reducing cost and time, allowing AI developers, even those with limited AI expertise, to easily integrate advanced AI features into their systems and applications. Given their versatility, WiseEye Modules are poised to become foundational technology for a wide range of IoT applications.
At the event, a visionary and innovative lineup of ultralow power WiseEye Module solutions will be on display, showcasing their potential to revolutionize AI-powered applications across industries.

Himax To Showcase AI-Powered Smart Tech Revolution at CES 2025

Himax and Seeed Studio Collaborate To Redefine IoT With AI-Powered SenseCAP Watcher, Debuting At CES 2025

Baird analyst Tristan Gerra maintains Himax Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) with a Outperform and raises the price target from $7 to $15.

Price Target

Analyst Ratings

Baird Maintains Outperform on Himax Techs, Raises Price Target to $15

U.S. stocks were lower, with the Nasdaq Composite falling around 0.2% on Thursday.
Shares of Ciena Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) rose sharply during Thursday's session after the company reported <a href="https://www.benzinga.com/24/12/42460647/ciena-q4-earnings-misses-eps-estimates-margins-decline-names-new-chair">better-than-expected fourth-quarter sales results.</a>
Ciena reported a fiscal fourth-quarter 2024 revenue decline of 0.5% year-on-year to $1.124 billion, beating the analyst consensus estimate of $1.104 billion.
Ciena shares jumped 14.8% to $84.11 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Jupiter Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares jumped 32.4% to $15.23.</li>
<li>Liquidity Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) shares climbed 31.6% to $33.88 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) shares gained 25.4% to $8.40.</li>
<li>Akso Health Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) surged 21.4% to $1.0461.</li>
<li>3D Systems Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) gained 19.5% to $4.0288 after the company inked a definitive agreement to sell its Geomagic software portfolio to <a href="https://www.benzinga.com/pressreleases/24/12/g42453783/3d-systems-announces-sale-of-geomagic-software-portfolio">Hexagon's Manufacturing Intelligence Division for $123 million</a>.</li>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) rose 19.1% to $23.73.</li>
<li>Gambling.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) gained 17.3% to $15.56 after the company announced it entered into a definitive agreement to acquire Odds Holdings.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) jumped 15.5% to $12.51 after the company announced it authorized a new corporate structure. Also, Guggenheim maintained a Buy rating on the stock and raised its price target from $11 to $12.5.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) gained 15.2% to $6.60.</li>
<li>Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) gained 11.4% to $29.74 after Jones Trading initiated coverage on the stock with a Buy rating and announced a price target of $36. Also, Cantor Fitzgerald reiterated an Overweight rating.</li>
<li>Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) rose 10.2% to $12.97 following a report from The Wall Street Journal indicating activist investor Starboard Value has taken a stake in the company.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) gained 6.7% to $25.19 after Baird raised its price target on the stock from $15 to $32.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42460676/jim-cramer-amd-ceo-lisa-su-built-an-amazing-company"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42460676/jim-cramer-amd-ceo-lisa-su-built-an-amazing-company">Jim Cramer Says This CEO &#8216;Built An Amazing Company,&#8217; Recommends Buying Netflix</a></li>
</ul>

Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) shares are trading higher in premarket on Wednesday following the announcement of a <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">new share buyback program.</a>
The company&#8217;s Board of Directors has approved the repurchase of up to $20 million worth of its American Depository Shares in the open market or through <a target="_blank" href="https://www.himax.com.tw/wp-content/uploads/2024/12/PR-Himax-announces-20-million-share-buyback-program-Final.pdf" rel="noreferrer noopener">privately negotiated transactions</a>.
This program, effective immediately, does not obligate Himax to repurchase any specific number of ADSs and can be modified or suspended at the company&#8217;s discretion, the company said.
Himax had $206.5 million of cash, cash equivalents and other financial assets at the end of September 2024, compared to $253.8 million a quarter ago and <a target="_blank" href="https://www.benzinga.com//node/41800131" rel="noreferrer noopener">$155.4 million at the same time last year.</a>
The sequential decrease in cash balance was mainly the result of a $50.7 million payment for annual dividends.
Himax&#8217;s President and CEO, Jordan Wu, emphasized that since its IPO in 2006, the company has returned over $1 billion to shareholders through buybacks and dividends.
The new share buyback program highlights Himax&#8217;s long-term growth prospects in high-growth sectors such as automotive, artificial intelligence, wafer-level optics, and OLED technologies.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42312593/this-pure-storage-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday" rel="noreferrer noopener">This Pure Storage Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday</a>
Wu also noted that the company remains focused on strategic investments in these high-growth sectors, which support its ongoing efforts to drive innovation and create long-term value for shareholders. The diversified portfolio positions Himax well to weather market fluctuations and capitalize on emerging opportunities across multiple industries.
The company&#8217;s inventories as of September 30 were $192.5 million, lower than the $203.7 million last quarter and $259.6 million in the same period last year, indicating a well-managed and balanced inventory level from quarter to quarter.
Price Action: HIMX shares are trading higher by 3.31% to $5.62 premarket at last check Wednesday.
Read This Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups" target="_blank" rel="noreferrer noopener">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>
Image: Shutterstock/ bangoland.

What's Going On With Himax Technologies Stock Wednesday?

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) today announced that its Board of Directors has approved a share buyback program. The program authorizes the Company to repurchase up to $20 million of the Company's American Depository Shares ("ADSs") in the open market or through privately negotiated transactions. The program will take effect immediately, does not obligate Himax to repurchase any specific amount of ADSs and may be modified or suspended at the Company's discretion at any time.

Himax's Board Approved Up To $20M Share Repurchase Program

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>), an industry leader in fabless display driver ICs and other semiconductors, today announced its industry-leading third-generation automotive TDDI IC, the HX83195 series, and automotive OLED touch controller IC, the HX8530 series, have commenced mass production in the third quarter. These new product launches highlight Himax's technological innovation capabilities, strengthen its market influence, solidify its leadership in the high-end automotive display market, and reaffirm its commitment to advancing automotive display technology. Himax holds a dominant position in the automotive LCD and OLED display markets, boasting industry-leading market share and the most comprehensive product portfolio in the industry.
HX83195 series third-generation Automotive TDDI pushes the limits of large-sized and high-resolution automotive displays, delivering an unparalleled touch experience
As the leader in the global automotive TDDI market, Himax boasts a more than 50% market share with accumulated TDDI shipments exceeding 70 million units to date, far surpassing those of its competitors. Driven by continuous innovation from the Company's engineering team, the third-generation TDDI HX83195 series has quickly become the preferred solution for automakers in Europe, the U.S., and Asia since its launch, and has been rapidly adopted in their latest vehicle designs. Zeekr, a high-end Chinese EV brand under the Geely group, became the first to adopt the HX83195 for its 16-inch, 3.2K x 2K high resolution in-cell touch display which began commenced mass production in the third quarter of the year.

Himax Leads Automotive Display Market with New TDDI and OLED Touch Controllers, Ramps Up Mass Production

Himax Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) reported a fiscal third-quarter revenue decline of 6.8% year-on-year to $222.41 million, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41800131/himax-technologies-inc-reports-third-quarter-2024-financial-results-provides-fourth-quarter-2024-g" rel="noreferrer noopener">analyst consensus estimate of $204.87 million</a>.&nbsp;Net revenues&nbsp;decreased 7.2% Q/Q.
Earnings per ADS was&nbsp;$0.07, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $0.03</a>. The stock price climbed after the print.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/11/41780976/chip-stocks-like-nvidia-broadcom-taiwan-semi-gain-after-trump-win-whats-going-on" rel="noreferrer noopener">Chip Stocks Like Nvidia, Broadcom, Taiwan Semi Gain After Trump Win &#8211; What&#8217;s Going On?</a>
The gross margin reached 30.1%, which is in line with its guidance.
Revenue from large display drivers was $30.7 million, a decrease of 21.2% Q/Q due to weaker monitor and TV IC sales due to customers&#8217; de-stocking amid challenging market conditions following substantial second-quarter replenishment for shopping festivals.&nbsp;
Small and medium-sized display driver revenue was $155.4 million, a decrease of 2.2% Q/Q, helped by stronger-than-expected sales in the automotive and tablet markets.
Revenue for non-driver business was $36.3 million, up 13.1% Q/Q, attributable&nbsp;to a double-digit sequential decline in Tcon sales, particularly for monitor application, as customers pulled forward their inventory purchases in the prior quarter.
Operating expenses for the quarter decreased 4.7% Y/Y to $60.8 million.
Operating&nbsp;income was $5.9 million compared to $11.1 million a year ago, and the margin declined by 200 bps to 2.6%, primarily due to&nbsp;lower sales and gross margins.&nbsp;
As of September 30, 2024, the company&#8217;s inventories were $192.5 million, markedly lower than&nbsp;the $203.7 million they had in the previous quarter.
Himax held $206.5 million of cash, cash equivalents, and other financial assets&nbsp;as of September 30, 2024.&nbsp;HIMX used $(3.14) million in operating cash flow, compared to a positive operating cash flow of $16.04 million a year ago.
Himax CEO Jordan Wu anticipates a challenging macro environment in the fourth quarter, focusing on managing expenses and enhancing efficiency. Wu expressed confidence in crucial growth areas like automotive, AI, WLO, and OLED, expecting these sectors to drive substantial business growth.
Regarding WLO, Wu highlighted progress in collaboration with FOCI on LPO/CPO production, noting early advancements in small-scale manufacturing. Additionally, Himax, FOCI, and top AI semiconductor and foundry partners are developing next-generation technology, which Wu believes will open new revenue streams and significantly boost future revenue and profit.
Q4 Guidance: Himax expects net revenues to grow flat to slightly&nbsp;down sequentially&nbsp;vs. the estimate of $202.59 million and EPADS of $0.093– $0.110&nbsp;versus&nbsp;the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$0.110&nbsp;estimate</a>.
Price Action: HIMX stock is up 3.36% at $6.15 premarket at&nbsp;the last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/11/41773691/us-listed-chinese-stocks-like-alibaba-jd-nio-fall-after-trumps-win-whats-going-on" target="_blank" rel="noreferrer noopener">US-Listed Chinese Stocks Like Alibaba, JD, Nio Fall After Trump&#8217;s Win &#8211; What&#8217;s Going On?</a></li>
</ul>

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="2">Fourth Quarter 2024 Guidance</td>
</tr>
<tr>
<td>Net Revenue:</td>
<td>Flat to slightly&nbsp;down sequentially</td>
</tr>
<tr>
<td>Gross Margin:</td>
<td>Flat to slightly up sequentially, depending on final product mix</td>
</tr>
<tr>
<td>Profit:</td>
<td>9.3 cents to 11.0 cents per diluted ADS</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Himax Technologies Expects Q4 Net Revenue Growth Of Flat To Slightly Down Sequentially Vs $202.59M Est, EPS Of $0.093-$0.110 Vs $0.110 Est

Earnings Beats

Himax Technologies Q3 2024 GAAP EPADS $0.07 Beats $0.03 Estimate, Sales $222.407M Beat $204.870M Estimate

Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>), an industry leader in fabless display driver ICs and other semiconductors, today announced the successful mass production of its cutting-edge In-Cell Touch TDDI (Touch and Display Driver Integration) solution, the HX83132, for high-end LCD AI laptops. The HX83132 has already been adopted by several leading panel makers across the board. By entering mass production during the third quarter of 2024, this marks a significant milestone for the first-of-its-kind, innovative product. As notebook brand customers increasingly prioritize product differentiation and value enhancement, the integration of touch functionality into displays of high-end laptops and AI PCs has emerged as a key trend. Himax HX83132 is featured in one marquee brand's first AI laptops, which boasts a 15.3-inch, 2.8K high-resolution touch display with a 120Hz refresh rate, significantly enhancing both interactivity and visual experience for seamless, intuitive user operations.
In-cell TDDI has become a mainstream technology for LCD displays, characterized by the seamless integration of touch functionality with display driver ICs. This integration not only simplifies the supply chain but also provides substantial cost benefits to panel manufacturers. Having pioneered the mass production of In-cell TDDI technology for mid-sized tablets and automotive displays in 2019, Himax has established itself as the industry leader by introducing an industry-first touch display solution supporting screen sizes of up to 45 inches for ultra-large automotive applications. The newly launched HX83132 series further expands the application of In-cell TDDI technology to laptops, boasting a unique design architecture that pairs seamlessly with timing controller (Tcon) chips supporting various eDP specifications which make it suitable for both mainstream and high-end LCD laptops. This TDDI and Tcon configuration effectively minimizes the need for supporting components, resulting in a more compact PCB size and narrower bezel design. The HX83132 series offers precise touch sensitivity, ensuring smooth human-machine interaction, significantly enhancing user experience and improving productivity.
The industry-leading HX83132 In-cell TDDI solution offers the following key features:
<ul>
<li>Flexible support for diverse panel sizes and resolutions: The advanced chip architecture can interconnect up to 6 chips, accommodating a wide range of laptop display needs with support for screen sizes up to 16 inches and resolutions up to 4K &nbsp;</li>
<li>Optimized and streamlined module architecture design: The HX83132 solution outperforms competition by providing more display and touch channels at the same resolution while utilizing fewer ICs. Additionally, the integrated microprocessor and level shifter minimize the need for external components, resulting in a smaller PCB size and enhanced design efficiency &nbsp;</li>
<li>Leveraging existing architecture for rapid In-cell Touch upgrades: The HX83132 features a state-of-the-art, integrated proprietary display driver and touch controller architecture. From a display perspective, it utilizes a standard Tcon architecture, which enables pure display panels, without the need for a dedicated Tcon for the In-cell touch functionality. Meanwhile, the TDDI integrates an in-house proprietary distributed touch microprocessor architecture, specifically designed to handle the high computational demands of touch data processing, effectively reducing development time &nbsp;</li>
<li>Comprehensive support for various power-saving operation scenarios: The HX83132 is compatible with eDP 1.4 and eDP 1.5 Tcons, and supports multiple power-saving features, including Panel Self Refresh (PSR) and User-Based Refresh Rate (UBRR), optimizing energy efficiency across different usage scenarios</li>
</ul>

Himax Begins Mass Production of Advanced In-Cell Touch Tech for AI Laptops

<table>
<tbody>
<tr>
<td colspan="2">Third&nbsp;Quarter 2024&nbsp;Guidance 
			&nbsp;</td>
</tr>
<tr>
<td>Net Revenue:</td>
<td>Decrease&nbsp;12.0%&nbsp;to&nbsp;17.0%&nbsp;sequentially</td>
</tr>
<tr>
<td>Gross Margin:</td>
<td>Around&nbsp;30%, depending on final product mix</td>
</tr>
<tr>
<td>Profit:</td>
<td>1.5 cents to 4.5 cents per diluted ADS</td>
</tr>
</tbody>
</table>

Himax Technologies Expects Q3 Net Revenue Decline Of 12%-17% QoQ Vs $235.2M Est, EPADS Of $0.015-$0.045 Vs $0.09 Est

Himax Technologies Q2 2024 GAAP EPADS $0.17 Beats $0.12 Estimate, Sales $239.622M Beat $229.340M Estimate

Shares of Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) fell sharply during Thursday's session <a href="https://www.benzinga.com/news/earnings/24/06/39411910/jabil-tops-q3-estimates-ceo-highlights-strategic-growth-in-ai-datacenters-and-ev-markets">following third-quarter results</a>.
Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, beating the analyst consensus estimate of $6.53 billion. The print manufacturing company's adjusted EPS of $1.89 beat the analyst consensus of $1.85, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Jabil said it expects fourth-quarter revenue of $6.3 billion – $6.9 billion (consensus: $6.8 billion) and adjusted EPS to $2.03 – $2.43 (consensus: $2.22).
Jabil shares dipped 7.8% to $116.37 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>MGO Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) shares jumped 222.8% to $1.48 after the company said it expects the pending acquisition of Spetner Associates to close in the second half of 2024, projecting it to increase annualized revenue to approximately $28 million.</li>
<li>Griid Infrastructure Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRDI#NASDAQ">GRDI</a>) climbed 89.3% to $1.48 after falling more than 10% on Tuesday.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) gained 89% to $2.58 after the company said it expects first customer deliveries of the i300 in the fourth quarter and anticipates selling over 5,000 units in the fiscal year ending September 30, 2025.</li>
<li>Reliance Global Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares climbed 60.5% to $0.6279. Reliance Global Group announced major enhancement of capital structure following cashless exercise of warrants.</li>
<li>Allurion Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) gained 50% to $1.598. Allurion announced publication of new data demonstrating lean mass gains in patients experiencing 14% weight loss.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) rose 43% to $0.1702 after jumping 19% on Tuesday.</li>
<li>Soluna Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) gained 23.3% to $5.96.</li>
<li>Femasys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) rose 22% to $1.1650 after receiving CE Mark approval from the EU MDR for its FemaSeed, FemVue, FemCerv, and FemCath products.</li>
<li>Molecular Partners AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) shares rose 21.1% to $9.63 after gaining 9% on Tuesday.</li>
<li>Surf Air Mobility Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NASDAQ">SRFM</a>) jumped 20.6% to $0.3850.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLT#NASDAQ">TBLT</a>) gained 20.2% to $3.75.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) surged 19.7% to $1.1303. MicroCloud Hologram entered into convertible note purchase agreements with investors for $28 million on June 18.</li>
<li>Presto Automation Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) shares climbed 19.2% to $0.0877after falling around 5% on Tuesday.</li>
<li>NanoViricides, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#NASDAQ">NNVC</a>) gained 16.5% to $1.91. Nanoviricides reported that the ultra-broad-spectrum antiviral NV-387, a Phase 2 Stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected influenza H3N2 mouse model.</li>
<li>Lobo EV Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) rose 16.4% to $2.47.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) gained 16% to $6.36 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $7 to $11.</li>
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) jumped 15.3% to $5.95.</li>
<li>Ranpak Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) climbed 13.7% to $6.49.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) rose 13.6% to $7.08 after the company announced insurance coverage of ANKTIVA across multiple states with first commercial doses administered.</li>
<li>Harrow, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) gained 12.2% to $19.81 after the company announced the manufacture of the first of three commercial-scale process performance qualification batches of TRIESENCE 40 mg/mL. Also the company announced that the second and third required PPQ batches are now scheduled.</li>
<li>ZKH Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZKH#NYSE">ZKH</a>) rose 11.4% to $3.92</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 11.3% to $12.91.</li>
<li>Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) jumped 11.1% to $8.23</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) surged 11% to $0.5849</li>
<li>Nexalin Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) gained 10% to $1.1450. Nexalin Technology shares jumped around 38% on Tuesday after the company was awarded a US patent on &#8216;Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimers and Dementia.&#8217;</li>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) shares climbed 7.8% to $17.45. On Tuesday, JP Morgan analyst Daniel Chen upgraded Bilibili from Neutral to Overweight and announced a $21 price target.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) gained 7% to $982.60 after Elon Musk indicated the company will provide server racks for the supercomputer that xAI is building.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) rose 5% to $162.36.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Trevena, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) fell 43.7% to $0.1993. Trevena announced preclinical TRV045 data for long-term analgestic effect in prelinical model of neuropathic pain. Also, the company announced TRV045 results provided director for additional NIH-initiated studies in epilepsy prevention and treatment.</li>
<li>Kaival Brands Innovations Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) shares declined 33.5% to $2.99 after gaining 8% on Tuesday.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) fell 29% to $1.10. Sonnet BioTherapeutics announced exercise of warrants for gross proceeds of $3.4 million.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) declined 25% to $2.1208. The company announced new data from the ongoing Phase 1b/2 clinical study on amezalpat2 (TPST-1120).</li>
<li>Nikola Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) declined 23.6% to $0.3672. Nikola announced 1-for-30 reverse stock split approved by board.</li>
<li>La Rosa Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) shares fell 23.5% to $1.37. La Rosa Holdings shares jumped 72% on Tuesday after the company entered a non-binding letter of intent to acquire a controlling interest in Red Door Title.</li>
<li>SYLA Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYT#NASDAQ">SYT</a>) dipped 21.7% to $1.70.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares dipped 21% to $0.6721 after the company announced a $2.5 million registered direct offering of 6.130 million shares at $0.41 per share.</li>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) fell 20.9% to $72.55.</li>
<li>NLS Pharmaceutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NLSP#NASDAQ">NLSP</a>) tumbled 20.3% to $0.1910 after jumping 82% on Tuesday.</li>
<li>DermTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMTK#NASDAQ">DMTK</a>) fell 19.4% to $0.1176.</li>
<li>Dunxin Financial Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXF#NASDAQ">DXF</a>) shares fell 19.4% to $0.1728 after dipping 17% on Tuesday.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) fell 15.1% to $25.76 amid post-IPO volatility.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) declined 15% to $2.2991 after B of A Securities downgraded the stock from Neutral to Underperform.</li>
<li>SRIVARU Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) shares fell 13.7% to $0.2150. SRIVARU, last week, announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) fell 12.2% to $1.8602. Actelis Networks shares jumped 84% on Tuesday after the company announced an agreement to serve as Carahsoft&#8217;s public sector distributor.</li>
<li>Jasper Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) declined 10.1% to $20.84. Jasper Therapeutics announced appointment of Svetlana Lucas Ph.D., to its Board of Directors.</li>
<li>GMS Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) declined 6.5% to $84.02 after the company reported mixed fourth-quarter financial results.</li>
<li>Nayax Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) fell 6.1% to $21.23.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNDA#NASDAQ">VNDA</a>) fell 5% to $6.03 after the company&#8217;s board determined that recent takeover proposals were not in its best interests.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39411935/this-skyworks-solutions-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday">This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a>

ALUR

APLD

ASNS

BILI

DMTK

ESPR

FEMY

GRDI

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

IBRX

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

KAVL

LOBO

LRHC

MBIO

MGOL

MOLN

NKLA

NLSP

NNVC

NYAX

OCUL

PACK

PRST

RELI

SLNH

SMCI

SONN

SRFM

SVMH

TBLT

Tempest Therapeutics, Inc. - Common Stock

TPST

TRVN

VNDA

ZAPP

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock moved upwards by 29.9% to $0.15 during Thursday's regular session. The market value of their outstanding shares is at $6.0 million. </li>
<li>Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) stock rose 16.95% to $6.04. The market value of their outstanding shares is at $827.3 million. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock increased by 15.93% to $1.09. The company's market cap stands at $89.7 million. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) shares rose 15.47% to $5.15. The market value of their outstanding shares is at $35.9 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) shares moved upwards by 14.05% to $5.51. The market value of their outstanding shares is at $21.6 million. </li>
<li>Himax Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) shares increased by 13.9% to $8.44. The company's market cap stands at $1.4 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>QXO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) stock declined by 17.9% to $75.37 during Thursday's regular session. The company's market cap stands at $50.0 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) stock declined by 15.31% to $0.47. The market value of their outstanding shares is at $16.7 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) stock declined by 12.27% to $1.86. The company's market cap stands at $6.2 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) stock declined by 11.01% to $0.63. The company's market cap stands at $7.7 million. </li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) shares decreased by 10.46% to $11.14. The market value of their outstanding shares is at $322.1 million. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) shares fell 9.68% to $0.35. The company's market cap stands at $33.5 million. The company's, Q4 earnings came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

AEHR

CISO

Next Technology Holding Inc. - Ordinary Shares

NXTT

QMCO

12 Information Technology Stocks Moving In Thursday's Intraday Session

U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Thursday.
Shares of KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) rose during Thursday's session as the company posted better-than-expected earnings and sales results for its <a href="https://www.benzinga.com/news/earnings/24/06/39410316/kb-home-analysts-boost-their-forecasts-after-upbeat-q2-results">second quarter on Tuesday</a>.
KB Home reported quarterly earnings of $2.15 per share, which beat the analyst consensus estimate of $1.78. Quarterly sales came in at $1.71 billion, which beat the analyst consensus estimate of $1.651 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
KB Home shares gained 4.2% to $70.91 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Ocular Therapeutix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) shares climbed 16% to $6.36 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $7 to $11.</li>
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) jumped 15.3% to $5.95.</li>
<li>Ranpak Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) rose 13.7% to $6.49.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) gained 13.6% to $7.08 after the company announced insurance coverage of ANKTIVA across multiple states with first commercial doses administered.</li>
<li>Harrow, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) shares jumped 12.2% to $19.81 after the company announced the manufacture of the first of three commercial-scale process performance qualification batches of TRIESENCE 40 mg/mL. Also the company announced that the second and third required PPQ batches are now scheduled.</li>
<li>ZKH Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZKH#NYSE">ZKH</a>) climbed 11.4% to $3.92</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) rose 11.3% to $12.91.</li>
<li>Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) surged 11.1% to $8.23</li>
<li>Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) gained 7.9% to $166.36 after the company announced the launch of Globant GUT.</li>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) shares jumped 7.8% to $17.45. On Tuesday, JP Morgan analyst Daniel Chen upgraded Bilibili from Neutral to Overweight and announced a $21 price target.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) climbed 7% to $982.60 after Elon Musk indicated the company will provide server racks for the supercomputer that xAI is building.</li>
<li>Accenture plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) gained 6.7% to $304.41 after the company posted quarterly results.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) rose 6.2% to $20.18.</li>
<li>WestRock Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRK#NYSE">WRK</a>) rose 5.6% to $52.48.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) gained 5% to $162.36.</li>
<li>Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) climbed 4.5% to $22.35.</li>
<li>Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) rose 4.1% to $65.76 after the company announced results from an interim analysis of a Phase 3 trial, showing Lenacapavir demonstrated 100% efficacy for HIV prevention and superiority to daily Truvada.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39410338/top-4-consumer-stocks-that-may-keep-you-up-at-night-this-month">Top 4 Consumer Stocks that May Keep You Up At Night This Month</a>

GILD

GLOB

KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday

HSINCHU and TAINAN, Taiwan, June 11, 2024 (GLOBE NEWSWIRE) -- FOCI Fiber Optic Communications, Inc. (TPEX: 3363) (&quot;FOCI&quot;), announced today that its Board of Directors has approved the issuance of 5,000,000 shares of common stock in a private placement financing with Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) (&quot;Himax&quot; or &quot;Company&quot;) participating as a strategic investor through its wholly-owned Taiwan subsidiary, Himax Technologies Limited. The subscription price is set at NT$104.4 per share (approximately US$3.2), resulting in gross proceeds of NT$522 million (approximately US$16 million), fully subscribed by Himax. Upon completion, Himax will hold a&nbsp;5.3%&nbsp;equity stake in FOCI.

Himax To Invest In FOCI's Private Placement; Merging Leading CPO Tech With Advanced Nano-Scale WLO For MCM Integration

Himax (HIMX) announced that its board of directors has approved a share buyback program. The program authorizes the company to repurchase up to $20...

Himax announces $20M share repurchase program

Himax Technologies (HIMX) has released an update. Himax Technologies has announced a $20 million share buyback program, highlighting its commitment...

Himax Technologies Announces $20 Million Share Buyback

Himax Technologies: Current Headwinds Hide A Bright Future

Himax jumps as analyst says it may be Nvidia, Taiwan Semi supplier

Unusual total active option classes on open include: Himax (HIMX), Revance (RVNC), Caesars (CZR), Warner Bros. Discovery (WBD), Riot Blockchain (RI...

Unusually active option classes on open December 12th

Biggest stock movers Thursday: WBS, ADBE, RIOT, NDSN, and more

In a report released yesterday, Tristan Gerra from Robert W. Baird maintained a Buy rating on Himax Technologies (HIMX – Research Report). The comp...

Robert W. Baird Reaffirms Their Buy Rating on Himax Technologies (HIMX)

Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone +

Himax (HIMX) and Seeed Studio announced their collaboration at CES 2025 to showcase Seeed's SenseCAP Watcher, a groundbreaking real-time, ultralow ...

Himax, Seeed Studio announce collaboration at CES 2025

Promising Stocks For 2025

AAPL

ADBE

ADTTF

ALTM

ARLTF

ATEYY

BBAGF

BEKE

BMWKY

BPAQF

BTAFF

CHWY

CLPIF

CRDF

DHLGY

DPSTF

FLNC

FPRUF

FPRUY

FRTAF

FRTAY

GASS

GRVY

HKTGF

ITOCF

ITOCY

MSFT

MURGF

MURGY

NDSN

NVDA

PAYO

PAYOW

RGTI

RNLSY

RNSDF

RVNC

SCGLF

SCGLY

SIXGF

SLTCY

SSLLF

TRMD

UPST

VALE

VLKAF

VLKPF

VODPF

VWAGY

VWAPY

ZION

ZIONP

Press Releases

Himax to Showcase Ultralow Power WiseEye AI Solution at Taipei Building Show

Himax and Liqxtal Technology Unveil Revolutionary Liquid Crystal Optical Technologies to be Showcased at CES 2025

Contracts

Himax and Seeed Studio Unite to Redefine IoT with Physical AI Agent SenseCAP Watcher Powered by WiseEye2 AI Processor at CES 2025

Himax to Unveil Groundbreaking 3D Naked-Eye Display Technology at CES 2025

Himax to Unveil State-of-the-Art WiseEye Module Solutions at CES 2025 Empowering Seamless AIoT Integration

Himax Solidifies Leadership in Automotive OLED and LCD Technologies at CES 2025

Himax to Showcase Industry-Leading 400K Nits Ultra-Luminous Color Sequential Front-lit LCoS Microdisplay at CES 2025

Himax to Introduce Expanded WiseEye PalmVein Suite at CES 2025 Featuring Groundbreaking Bimodal Palm Vein and Face Authentication Technologies for Multimodal Authentication

Himax Partners with Ganzin to Launch Best-in-Class Eye-Tracking Solution at CES 2025

Himax and Calumino Collaborate to Unveil Next Generation CMOS Imager-Based Optical Thermal Sensor

Comments

Himax Techs

Himax Techs (HIMX) Forecast

Himax Techs (NASDAQ:HIMX) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga